Coronavirus impact: Aim’s healthcare companies firmly in favour

The quest to find a test, treatment or vaccine for coronavirus is heating up. Academics and companies have shifted resources away from traditional operations to fight the Covid-19 battle and identify solutions which could make a big difference to how the UK deals with the illness. Successful companies are likely to enjoy an enormous boost amid the demand of a population under siege. 

The challenges posed by Covid-19 could provide a big turning point for the UK's small pharma industry which has languished for several years as the plethora of companies which listed around 2015 have struggled to commercialise treatments. Now money is flowing freely into the market as it tries to battle the pandemic - healthcare is key to reducing the human and financial catastrophe of coronavirus.